Skip to content
10-Q

Quarterly Report

RHYTHM PHARMACEUTICALS, INC. RYTM

0001104659-25-106264

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 66.74M sh
Shares Diluted Q3 2025 · Sep 30, 2025 66.26M sh
Shares Diluted Q3 2025 · Sep 30, 2025 64.35M sh
Shares Diluted Q3 2025 · Sep 30, 2024 61.22M sh
Shares Diluted Q3 2025 · Sep 30, 2024 60.79M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$90.29M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$95.03M
Long Term Debt Q3 2025 · Sep 30, 2025 $103.41M
Long Term Debt Q3 2025 · Dec 31, 2024 $108.27M
Short Term Debt Q3 2025 · Sep 30, 2025 $5.56M
Short Term Debt Q3 2025 · Dec 31, 2024 $1.54M
Short Term Investments Q3 2025 · Sep 30, 2025 $363.97M
Short Term Investments Q3 2025 · Dec 31, 2024 $231.43M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $52.08M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $89.14M
Stockholders Equity Q3 2025 · Sep 30, 2025 $148.82M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$11.91M
Stockholders Equity Q3 2025 · Mar 31, 2025 $18.95M
Stockholders Equity Q3 2025 · Dec 31, 2024 $21.73M
Stockholders Equity Q3 2025 · Sep 30, 2024 $11.22M
Stockholders Equity Q3 2025 · Jun 30, 2024 $39.34M
Stockholders Equity Q3 2025 · Mar 31, 2024 $61.58M
Stockholders Equity Q3 2025 · Dec 31, 2023 $169.76M
Current Liabilities Q3 2025 · Sep 30, 2025 $104.27M
Current Liabilities Q3 2025 · Dec 31, 2024 $115.52M
Total Liabilities Q3 2025 · Sep 30, 2025 $211.19M
Total Liabilities Q3 2025 · Dec 31, 2024 $227.72M
Current Assets Q3 2025 · Sep 30, 2025 $494.8M
Current Assets Q3 2025 · Dec 31, 2024 $374.2M
Total Assets Q3 2025 · Sep 30, 2025 $506.87M
Total Assets Q3 2025 · Dec 31, 2024 $392.27M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.82
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.38
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.73
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.62
Eps Basic Q3 2025 · Sep 30, 2025 −$0.82
Eps Basic Q3 2025 · Sep 30, 2025 −$2.38
Eps Basic Q3 2025 · Sep 30, 2024 −$0.73
Eps Basic Q3 2025 · Sep 30, 2024 −$3.62
Sga Expense Q3 2025 · Sep 30, 2025 $52.43M
Sga Expense Q3 2025 · Sep 30, 2025 $137.46M
Sga Expense Q3 2025 · Sep 30, 2024 $35.38M
Sga Expense Q3 2025 · Sep 30, 2024 $106.17M
Rd Expense Q3 2025 · Sep 30, 2025 $46.03M
Rd Expense Q3 2025 · Sep 30, 2025 $125.31M
Rd Expense Q3 2025 · Sep 30, 2024 $37.93M
Rd Expense Q3 2025 · Sep 30, 2024 $196.79M
Net Income Q3 2025 · Sep 30, 2025 −$52.9M
Net Income Q3 2025 · Sep 30, 2025 −$149.03M
Net Income Q3 2025 · Jun 30, 2025 −$46.63M
Net Income Q3 2025 · Mar 31, 2025 −$49.5M
Net Income Q3 2025 · Sep 30, 2024 −$43.64M
Net Income Q3 2025 · Sep 30, 2024 −$217.31M
Net Income Q3 2025 · Jun 30, 2024 −$32.26M
Net Income Q3 2025 · Mar 31, 2024 −$141.37M
Operating Income Q3 2025 · Sep 30, 2025 −$52.65M
Operating Income Q3 2025 · Sep 30, 2025 −$144.95M
Operating Income Q3 2025 · Sep 30, 2024 −$43.89M
Operating Income Q3 2025 · Sep 30, 2024 −$224.25M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $5.5M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $14.69M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $3.83M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $9.58M
Revenue Q3 2025 · Sep 30, 2025 $51.3M
Revenue Q3 2025 · Sep 30, 2025 $132.5M
Revenue Q3 2025 · Sep 30, 2024 $33.25M
Revenue Q3 2025 · Sep 30, 2024 $88.3M